Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
509201000001115 | Glytactin Build 20/20 oral powder 30g sachets (Cambrooke Therapeutics) 30 sachet | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
509221000001110 | Glytactin Build 20/20 oral powder 30g sachets (Cambrooke Therapeutics) 30 sachet (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1927661000001112 | Glytactin Build 20/20 oral powder 30g sachets (Cambrooke UK Ltd) 30 sachet | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1927671000001119 | Glytactin Build 20/20 oral powder 30g sachets (Cambrooke UK Ltd) 30 sachet (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2390981000001110 | Glytactin Build 20/20 oral powder 30g sachets neutral (Cambrooke UK Ltd) 30 sachet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2390991000001112 | Glytactin Build 20/20 oral powder 30g sachets neutral (Cambrooke UK Ltd) 30 sachet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets